久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Latest

Rapidly developed coronavirus vaccine set for testing

By AI HEPING in New York | China Daily Global | Updated: 2020-02-27 01:39
Share
Share - WeChat

A rapidly developed coronavirus vaccine will be tested on healthy volunteers in the US in April, the director of the National Institute of Allergy and Infectious Diseases (NIAID) said Tuesday.

The vaccine, by drugmaker Moderna and NIAID, will be tested on 20 to 25 humans to determine whether two doses will be safe and generate an immune response to protect against infection, with results available in July or August, NIAID's Dr Anthony Fauci told The Wall Street Journal.

NIAID is part of the National Institutes of Health (NIH), an agency of the US Department of Health and Human Services. The Coalition for Epidemic Preparedness Innovations (CEPI), an international funding body, is also backing the effort.

Also on Tuesday, NIH announced that the first clinical trial testing of Gilead Sciences' antiviral drug remdesivir in a hospitalized patient with the coronavirus has started, according to Reuters.

The participant is an American who was repatriated after being quarantined in Japan aboard the cruise ship Diamond Princess and is being conducted at the University of Nebraska Medical Center in Omaha, NIH said.

The World Health Organization (WHO) said Monday that remdesivir is showing signs of helping to treat the coronavirus.

A successful trial of Moderna's vaccine — mRNA-1273 — would be followed by further studies and regulatory hurdles, Fauci said, meaning a coronavirus vaccine would not be ready for widespread distribution until at least next year.

Moderna said the vaccine was developed after obtaining genetic information on the coronavirus from China.

Referring to the speed of the drug's development and expected clinical trial, Fauci said it is "unquestionably the world indoor record. Nothing has ever gone that fast."

However, it's uncertain whether the drug will work, considering that the gene-based technology it uses hasn't yet resulted in an approved human vaccine.

Even if it isn't ready for widespread distribution until next year, Fauci told the newspaper that it's possible the spread of the coronavirus could lessen during warmer months but return next winter and become a seasonal virus like the flu.

"The only way you can completely suppress an emerging infectious disease is with a vaccine," he said. "If you want to really get it quickly, you're using technologies that are not as time-honored as the standard — what I call antiquated — way of doing it."

Moderna was founded in 2010 to develop drugs and vaccines. In 2018 it opened a manufacturing site in Norwood, Massachusetts, near the company's Cambridge headquarters. The company is targeting cancer, heart disease and infectious diseases. It hasn't brought any drugs or vaccines to market.

The first trial will be conducted at NIAID's clinical trials unit in Bethesda, Maryland, where the agency is based. If the first one is successful, a second trial of hundreds or thousands of participants could begin, which could take six to eight months, he said.

That trial could be conducted partly in the US but also in other regions where the virus is spreading, so the testing could gauge whether the vaccine reduces infection rates.

If the second trial is positive, the vaccine could be ready for widespread use, Fauci said. How widely the virus has spread by then will determine whether it is given to targeted groups, such as healthcare workers, or more broadly to the general population, he said.

Health officials and pharmaceutical companies around the world are racing to identify treatments or a vaccine to help fight the coronavirus, which has infected more than 80,000 people around the world.

Johnson & Johnson, GlaxoSmithKline?and Gilead are among the drugmakers working on vaccines, as are government scientists, including some at NIAID.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 久久福利影视 | 亚洲精品人成在线观看 | 91热播 | 日本不卡高清免费 | 1级黄色毛片 | 一级毛片儿 | 91精品一区二区三区在线观看 | 亚洲美女色成人综合 | 国产精品免费aⅴ片在线观看 | 久久草在线精品 | 国产成人综合怡春院精品 | 成人免费观看永久24小时 | 国产欧美在线观看不卡 | 亚州免费视频 | 亚洲男人的天堂成人 | 99视频免费| 超清波多野结衣精品一区 | 久草免费小视频 | 欧美黄色免费 | 欧美69视频在线 | 91久久夜色精品国产网站 | 免费在线成人 | 男子操女子 | 亚洲国产精品久久久久久网站 | 亚洲经典三级 | 亚洲国产高清在线 | 欧美三级一区二区 | 在线观看中文字幕国产 | 久久大胆视频 | 美女视频黄a视频美女大全 美女视频黄a视频免费全程 | 国产精品资源手机在线播放 | 中文字幕最新中文字幕中文字幕 | 欧洲成人全免费视频网站 | 国产欧美曰韩一区二区三区 | 九九干 | 国产一区二区三区影院 | 欧美综合自拍亚洲综合百度 | 欧美成人鲁丝片在线观看 | 一区二区三区欧美日韩国产 | 国产亚洲精品一区二区在线播放 | 欧美色xx|